Advanced Biomed Inc. (NASDAQ:ADVB) Stock Short Interest Declines 39.8%

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totaling 9,845 shares, a decrease of 39.8% from the August 31st total of 16,357 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average trading volume of 110,241 shares, the short-interest ratio is presently 0.1 days.

Advanced Biomed Price Performance

NASDAQ:ADVB opened at $6.32 on Wednesday. Advanced Biomed has a 1-year low of $3.61 and a 1-year high of $24.23. The company has a 50-day moving average of $8.85 and a 200 day moving average of $6.35. The firm has a market cap of $10.44 million, a PE ratio of 1.31 and a beta of -0.29.

Analyst Ratings Changes

Several research firms have recently weighed in on ADVB. Weiss Ratings raised shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 23rd. Wall Street Zen upgraded Advanced Biomed to a “hold” rating in a report on Saturday, August 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.